This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Study of an Autologous Neo-Kidney Augment in Patie...
Clinical trial

Study of an Autologous Neo-Kidney Augment in Patients With Chronic Kidney Disease

Read time: 1 mins
Last updated:30th Apr 2013
The primary purpose of this study is to assess the safety and optimal delivery of the Neo-Kidney Augment (NKA) when implanted at one site in a recipient kidney. NKA is made from expanded autologous, homologous, selected renal cells (SRC) obtained from the patient's kidney biopsy.
Category Value
Study start date 2013-04-30

View full details